TENGION INC
DelistedCIK 1296391fmd_0A0PDMH7KDTFT3KZV4T4CRCDD7Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2003 to Sep 30, 2014, 25 periods
| Line item | FY2004 | FY2005 | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Research and development | – | – | – | – | – | 18 | 13 | 13 | 10 | 9 |
| Total operating expenses | – | – | – | – | – | 28 | 24 | 33 | 16 | 17 |
| Interest expense | – | – | – | – | – | 3 | 2 | 1 | 3 | 8 |
| Interest and investment income | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 |
| Income before taxes | – | – | – | – | – | – | – | – | (16) | (17) |
| Net income | (2) | (10) | (21) | (31) | (42) | (30) | (26) | (19) | (17) | (19) |
| Net income to common shareholders | – | – | – | – | – | (44) | (30) | (19) | – | – |